Haemonetics Sets Date for Publishing Second Quarter Fiscal Year 2023 Results: November 7, 2022
Haemonetics Corporation (NYSE: HAE) announced plans to release its second quarter fiscal year 2023 financial results on November 7, 2022, at 6:00 am ET.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Haemonetics Corporation (NYSE: HAE) announced plans to release its second quarter fiscal year 2023 financial results on November 7, 2022, at 6:00 am ET. An accompanying conference call will be held at 8:00 am ET the same day for investors and analysts to discuss the results. Participants can access the call via teleconference or live webcast on Haemonetics' investor relations website. A replay of the call will be available for one year starting at 11:00 am ET on November 7, 2022.
Details
News Market Reaction – HAE
The recorded move for HAE in the trading session of this news was -1.24%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
BOSTON, Oct. 6, 2022 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that the Company intends to publish second quarter fiscal year 2023 financial results at 6:00 am ET on Monday, November 7, 2022. The Company will hold a conference call with investors and analysts to discuss results and answer questions at 8:00 am ET on November 7, 2022.
The call can be accessed via teleconference at: Q2 2023 Haemonetics Corporation Earnings Conference Call. Once registration is completed, participants will receive a dial-in number along with a personalized PIN to access the call. While not required, it is recommended that participants join 10 minutes prior to the event start.
A live webcast of the call can be accessed on Haemonetics' investor relations website. Webcast Link:https://edge.media-server.com/m6/p/qyrbnnof https://edge.media-server.com/mmc/p/jmqoyvd8
A replay of the conference call and webcast will be available for one year beginning on November 7, 2022 at 11:00 am ET using the conference call webcast link provided in this press release.
Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing a suite of innovative medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. Our technology addresses important medical markets: blood and plasma component collection, the surgical suite and hospital transfusion services. To learn more about Haemonetics, visit www.haemonetics.com.
Investor Contact:
Olga Guyette, Sr. Director, Investor Relations & Treasury
(781) 356-9763
olga.guyette@haemonetics.com
Media Contact:
Josh Gitelson, Director, Global Communications
(781) 356-9776
josh.gitelson@haemonetics.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/haemonetics-sets-date-for-publishing-second-quarter-fiscal-year-2023-results-november-7-2022-301643084.html
SOURCE Haemonetics Corporation
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.